Department Overview The OHSU Knight Cancer Institute is a pioneer in personalized cancer treatment and research, led by Dr. Brian Druker, whose development of Gleevec transformed Chronic Myeloid Leukemia from a fatal disease to a manageable
Department Overview The OHSU Knight Cancer Institute is an internationally recognized leader in cancer research and care, powered by a historic $2 billion gift from Phil and Penny Knight. With a bold mission to revolutionize cancer
Department Overview The OHSU Knight Cancer Institute is an internationally recognized leader in cancer research and care, powered by a historic $2 billion gift from Phil and Penny Knight. With a bold mission to revolutionize cancer
Department Overview The Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. We are comprised of biologists, chemists, biomedical engineers, computationalists, and clinicians
Department Overview The Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. We are comprised of biologists, chemists, biomedical engineers, computationalists, and clinicians